COVID-19 vaccine trial, raising hopes that initial results will be released soon.Interim trial data from Pfizer and BioNTech released on Monday indicated that its vaccine candidate was more than 90% effective.“We appreciate the collaboration we have had to date with Swissmedic to address this ongoing public health emergency," said Stéphane Bancel, Chief Executive Officer of Moderna. “We are pleased with the encouraging Phase 1 interim analysis of mRNA-1273 in the older adult population, which we recently published together with the NIH.
We look forward to our expected first review of our interim efficacy data from our Phase 3 data." (With Agency Inputs)Click here to read the Mint ePaperMint is now on Telegram.